Gael McWalter

1.1k total citations
9 papers, 866 citations indexed

About

Gael McWalter is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Gael McWalter has authored 9 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Gael McWalter's work include Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Genomics and Diagnostics (3 papers). Gael McWalter is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Genomics and Diagnostics (3 papers). Gael McWalter collaborates with scholars based in United Kingdom, Romania and Hungary. Gael McWalter's co-authors include Simon Dearden, Rose McCormack, Jill Walker, Tsveta Milenkova, Tudor–Eliade Ciuleanu, Jean‐Yves Douillard, Gyula Ostoros, Alan Webster, Manuel Cobo and Rebecca Cole and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Gael McWalter

9 papers receiving 858 citations

Peers

Countries citing papers authored by Gael McWalter

Since Specialization

Citations

This map shows the geographic impact of Gael McWalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gael McWalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gael McWalter more than expected).

Fields of papers citing papers by Gael McWalter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gael McWalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gael McWalter. The network helps show where Gael McWalter may publish in the future.

Co-authorship network of co-authors of Gael McWalter

This figure shows the co-authorship network connecting the top 25 collaborators of Gael McWalter. A scholar is included among the top collaborators of Gael McWalter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gael McWalter. Gael McWalter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Impact of KRAS codon subtypes from a randomised phase II trial of selumetinib plus docetaxel in KRAS mutant advanced non-small-cell lung cancer 2015 ·British Journal of Cancer ·Pasi A. Jänne, Ian C. P. Smith, Gael McWalter, Helen Mann, Brian Dougherty, Jill Walker, Maria Orr, Darren Hodgson, Alice T. Shaw, José Rodrigues Pereira, G. Jeannin, Johan Vansteenkiste, C.H. Barrios, Fábio Franke, Lucio Crinò, Paul D. Smith	59
2	Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status 2014 ·Journal of Thoracic Oncology ·Jean‐Yves Douillard, Gyula Ostoros, Manuel Cobo, Tudor–Eliade Ciuleanu, Rebecca Cole, Gael McWalter, Jill Walker, Simon Dearden, Alan Webster, Tsveta Milenkova, Rose McCormack	348
3	KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib 2013 ·European Journal of Cancer ·John Smith, Laura Brooks, Paulo M. Hoff, Gael McWalter, Simon Dearden, Shethah Morgan, David M. Wilson, Jane Robertson, Juliane M. Jürgensmeier	14
4	Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS) 2013 ·Lung Cancer ·James Chih‐Hsin Yang, Yi‐Long Wu, Valorie F. Chan, Johan Kurnianda, Kazuhiko Nakagawa, Nagahiro Saijo, Masahiro Fukuoka, Gael McWalter, Rose McCormack, Tony Mok	36
5	Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines 2012 ·BMC Medical Genomics ·Andreas Schlicker, Garry Beran, Christine M. Chresta, Gael McWalter, Alison Pritchard, Susie Weston, Sarah Runswick, Sara Davenport, (unknown), D Castro, George M. Orphanides, Tim French, Lodewyk F.A. Wessels	180
6	Use of KRAS mutation status to predict clinical outcomes in patients with metastatic colorectal cancer (mCRC) treated with the VEGF signaling inhibitor cediranib. 2011 ·Journal of Clinical Oncology ·(unknown), (unknown), Laura A. Pike, Jane Robertson, (unknown), Gael McWalter, Darrell M. Wilson, Jeff Smith	2
7	A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples 2010 ·Journal of Experimental & Clinical Cancer Research ·Gillian Ellison, Emma Donald, Gael McWalter, (unknown), Lynn M. Fletcher, James Sherwood, Mireille Cantarini, Maria Orr, Georgina Speake	132
8	Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study 2009 ·British Journal of Cancer ·Ruth Board, Gillian Ellison, Maria Orr, Karin Kemsley, Gael McWalter, (unknown), Simon Dearden, C. Morris, Malcolm Ranson, Mireille Cantarini, Caroline Dive, Andrew Hughes	78
9	Identification of Biomarkers in Human Head and Neck Tumor Cell Lines That Predict For In Vitro Sensitivity to Gefitinib 2009 ·Clinical and Translational Science ·D. Mark Hickinson, Gayle Marshall, Garry Beran, Marileila Varella‐Garcia, Elizabeth Mills, (unknown), (unknown), (unknown), Gael McWalter, Rose McCormack, Paul A. Bunn, Tim French, (unknown), Brian R. Holloway, Fred R. Hirsch, Georgina Speake	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact